Griseofulvin (Qualitest Pharmaceuticals)
Welcome to the PulseAid listing for the Griseofulvin drug offered from Qualitest Pharmaceuticals. This Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Qualitest Pharmaceuticals |
| NON-PROPRIETARY NAME: | Griseofulvin |
| SUBSTANCE NAME: | GRISEOFULVIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-10-08 |
| END MARKETING DATE: | 2018-02-28 |
Griseofulvin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Griseofulvin from Qualitest Pharmaceuticals |
| LABELER NAME: | Qualitest Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 125(mg/5mL) |
| START MARKETING DATE: | 2010-10-08 |
| END MARKETING DATE: | 2018-02-28 |
| PRODUCT ID: | 0603-9171_edba0d01-d72e-48de-9528-9ddf9fd1a838 |
| PRODUCT NDC: | 0603-9171 |
| APPLICATION NUMBER: | ANDA065438 |
Other GRISEOFULVIN Pharmaceutical Manufacturers / Labelers:
